[Vadilex in otorhinolaryngologic diseases].
D000284:Administration, Oral; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000367:Age Factors; D000605:Amino Alcohols / Q000627:therapeutic use*; D006259:Craniocerebral Trauma / Q000150:complications; D003638:Deafness / Q000188:drug therapy*; D004585:Electrooculography; D006801:Humans; D007275:Injections, Intravenous; D002546:Ischemic Attack, Transient / Q000150:complications; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use; D011379:Prognosis; D014012:Tinnitus / Q000188:drug therapy*; D014717:Vertigo / Q000188:drug therapy* / Q000209:etiology; D014724:Vestibular Function Tests
D000317:Adrenergic alpha-Antagonists; D000605:Amino Alcohols; D010880:Piperidines
Le Vadilex dans les indications O.R.